Brainstorm Cell Therapeutics | BCLI - Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Biogen USD 545.2M 38.6M 2025-09
Brainstorm Cell Therapeutics USD 1.07M 64K 2025-09
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.21M 120K 2025-12
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 91.72M 67.02M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Mesoblast USD 28.54M 9.69M 2025-12